CSIMarket
 


Phasebio Pharmaceuticals Inc.  (PHAS)
Other Ticker:  
 

Phasebio Pharmaceuticals's Tangible Leverage Ratio

PHAS's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth


In II Quarter 2022 Phasebio Pharmaceuticals had stockholder deficit.

Within Major Pharmaceutical Preparations industry Phasebio Pharmaceuticals Inc. achieved the lowest Tangible Leverage Ratio in the second quarter 2022. While total ranking remained the same in the second quarter 2022 compared to the previous quarter at no. .

Explain Tangible Leverage Ratio?
What is PHAS Market Share?
What are PHAS´s Total Liabilities?


PHAS Tangible Leverage Ratio (Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
Y / Y Tangible Equity Change - - - - -
Y / Y Total Liabilities Change 16.49 % 64.82 % 105.41 % 165.22 % 225.36 %
Tangible Leverage Ratio MRQ - - - - -
PHAS's Total Ranking # # # # #
Seq. Tangible Equity Change - - - - -
Seq. Total Liabilities Change -1.06 % -7.21 % 18.72 % 6.88 % 40 %



Tangible Leverage Ratio second quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #


Tangible Leverage Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Phasebio Pharmaceuticals's Tangible Equity $ -117 Millions Visit PHAS's Balance sheet
Phasebio Pharmaceuticals's Total Liabilities $ 140 Millions Visit PHAS's Balance sheet
Source of PHAS's Sales Visit PHAS's Sales by Geography


Cumulative Phasebio Pharmaceuticals's Tangible Leverage Ratio

PHAS's Tangible Leverage Ratio for the trailling 12 Months

PHAS Tangible Leverage Ratio

(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
Y / Y Tangible Equity TTM Growth - - - - -
Y / Y Total Liabilities TTM Growth 16.49 % 64.82 % 105.41 % 165.22 % 225.36 %
Tangible Leverage Ratio TTM - - - - -
Total Ranking TTM
Seq. Tangible Equity TTM Growth - - - - -
Seq. Total Liabilities TTM Growth -1.06 % -7.21 % 18.72 % 6.88 % 40 %


On the trailing twelve months basis During the 12 months period ending II Quarter 2022 company had stockholder deficit.
Tangible Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry PHAS recorded the lowest Tangible Leverage Ratio. While total ranking remained unchanged compared to previous 12 month period at no. 0.

Explain Tangible Leverage Ratio?
What is PHAS Market Share?
What are PHAS´s Total Liabilities?

TTM Tangible Leverage Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Within the Market #


trailing twelve months Tangible Leverage Ratio Statistics
High Average Low
0 0 0
 




Companies with similar Tangible Leverage Ratio in the quarter ending Jun 30 2022, within Major Pharmaceutical Preparations Industry Tangible Leverage RatioJun 30 2022 MRQ Total LiabilitiesJun 30 2022 MRQ Tangible Equity

Date modified: 2022-08-16T01:02:42+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com